Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorUniversity of California, Davis

About this trial

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Eligibility criteria

Qualifiers

18 years of age or younger at the onset of disease

Presence of Vascular Thrombosis

UC Davis patient

Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma

Disqualifiers

Infants born to mothers with APS

Infants with congenital thrombophilia

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

University of California, Davis

Lead sponsor

Ministry of Higher Education, Science and Technology, Solvenia

Collaborator